litlas
Log inCreate account

Russell E. Ware

Active 1988–2025

110
Papers
18,133
Citations
73
h-index
103
i10-index

Citations

Citations per year for Russell E. Ware1985: 1 citations1990: 1 citations1991: 1 citations1992: 1 citations1993: 4 citations1994: 2 citations1995: 4 citations1996: 1 citations1997: 6 citations1998: 1 citations1999: 4 citations2000: 8 citations2001: 27 citations2002: 23 citations2003: 49 citations2004: 55 citations2005: 62 citations2006: 56 citations2007: 75 citations2008: 81 citations2009: 64 citations2010: 109 citations2011: 111 citations2012: 124 citations2013: 115 citations2014: 126 citations2015: 126 citations2016: 128 citations2017: 138 citations2018: 140 citations2019: 593 citations2020: 630 citations2021: 463 citations2022: 375 citations2023: 270 citations2024: 518 citations2025: 161 citations2026: 5 citations1986–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,510 citing papers, 36.9% of this breakdownUnited Kingdom: 296 citing papers, 7.2% of this breakdownFrance: 209 citing papers, 5.1% of this breakdownGermany: 165 citing papers, 4% of this breakdownItaly: 144 citing papers, 3.5% of this breakdownCanada: 133 citing papers, 3.3% of this breakdownNetherlands: 119 citing papers, 2.9% of this breakdownBrazil: 88 citing papers, 2.2% of this breakdownSwitzerland: 86 citing papers, 2.1% of this breakdownNigeria: 85 citing papers, 2.1% of this breakdownAustralia: 74 citing papers, 1.8% of this breakdownIndia: 74 citing papers, 1.8% of this breakdown
0%36.9%Other 27.1%

Institutions

Fields

  • Medicine80.9%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Immunology and Microbiology4.4%
  • Engineering2.2%
  • Health Professions1.2%
  • Computer Science0.6%
  • Other2.1%

Topics

  • Hemoglobinopathies and Related Disorders21.7%
  • Iron Metabolism and Disorders11.3%
  • Blood groups and transfusion7.8%
  • Prenatal Screening and Diagnostics3.3%
  • Erythrocyte Function and Pathophysiology3.1%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment2.6%
  • Other50.2%

Coauthors

All papers

Open in search
  1. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

    Authors: Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga, Russell E. Ware, Videlis Nduba, Amal El‐Beshlawy, Hoda Hassab, Maureen M. Achebe, Salam Alkindi, R. Clark Brown, David Diuguid, Paul Telfer, Dimitris A. Tsitsikas, Ashraf Elghandour, Victor R. Gordeuk, Julie Kanter, Miguel R. Abboud, Joshua Lehrer‐Graiwer, Margaret Tonda, Allison Intondi, Barbara Tong, Jo Howard - New England Journal of Medicine 2019 cited by 609

  2. Management of Sickle Cell Disease

    Authors: Barbara P. Yawn, George R. Buchanan, Araba Afenyi‐Annan, Samir K. Ballas, Kathryn L. Hassell, Allison James, Lanetta Jordan, Sophie Lanzkron, Richard Lottenberg, William Savage, Paula Tanabe, Russell E. Ware, M. Hassan Murad, Jonathan C. Goldsmith, Eduardo Ortíz, Robinson Fulwood, Ann Horton, Joylene John‐Sowah - JAMA 2014 cited by 1,562

  3. Sickle cell disease

    Authors: Russell E. Ware, Mariane de Montalembert, Léon Tshilolo, Miguel R. Abboud - The Lancet 2017 cited by 943

  4. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission

    Authors: Frédéric B. Piel, David C. Rees, Michael R. DeBaun, Obiageli Nnodu, Brigitte Ranque, Alexis A. Thompson, Russell E. Ware, Miguel R. Abboud, Allistair Abraham, Emmanuela E. Ambrose, Biree Andemariam, Roshan Colah, Raffaella Colombatti, Nicola Conran, Fernando Ferreira Costa, Robert M. Cronin, Mariane de Montalembert, Jacques Élion, Erica B. Esrick, Anthea Greenway, Ibrahim M. Idris, David-Zacharie Issom, Dipty Jain, Lori C. Jordan, Zane Kaplan, Allison A. King, Michele A. Lloyd-Puryear, Samuel A. Oppong, Akshay Sharma, Lillian Sung, Léon Tshilolo, Diana J. Wilkie, Kwaku Ohene‐Frempong - The Lancet Haematology 2023 cited by 160

  5. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa

    Authors: Léon Tshilolo, George Tomlinson, Thomas N. Williams, Brígida Santos, Peter Olupot‐Olupot, Adam Lane, Banu Aygün, Susan E. Stuber, Teresa Latham, Patrick T. McGann, Russell E. Ware - New England Journal of Medicine 2018 cited by 376

  6. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

    Authors: Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella, Caterina P. Minniti, Sohail Rana, Courtney D. Thornburg, Zora R. Rogers, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lynn Wynn, Abdullah Kutlar, F. Daniel Armstrong, Beatrice Files, Jonathan C. Goldsmith, Myron A. Waclawiw, Xiangke Huang, Bruce Thompson - The Lancet 2011 cited by 793

  7. Hydroxyurea therapy for sickle cell anemia

    Authors: Patrick T. McGann, Russell E. Ware - Expert Opinion on Drug Safety 2015 cited by 303

  8. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa

    Authors: Chandy C. John, Robert O. Opoka, Teresa Latham, Heather Hume, Catherine Nabaggala, Phillip Kasirye, Christopher M. Ndugwa, Adam Lane, Russell E. Ware - New England Journal of Medicine 2020 cited by 151

  9. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

    Authors: Russell E. Ware, Barry R. Davis, William H. Schultz, R. Clark Brown, Banu Aygün, Sharada A. Sarnaik, Isaac Odame, Beng Fuh, Alex George, William Owen, Lori Luchtman‐Jones, Zora R. Rogers, Lee Hilliard, Cynthia Gauger, Connie M. Piccone, Margaret T. Lee, Janet L. Kwiatkowski, Sherron M. Jackson, Scott T. Miller, Carla W. Roberts, Matthew M. Heeney, Theodosia A. Kalfa, Stephen C. Nelson, Hamayun Imran, Kerri Nottage, Ofelia Álvarez, Melissa Rhodes, Alexis A. Thompson, Jennifer Rothman, Kathleen J. Helton, Donna R. Roberts, Jamie L. Coleman, Melanie J. Bonner, Abdullah Kutlar, Niren Patel, John C. Wood, Linda B. Piller, Peng Wei, Judy Luden, Nicole A. Mortier, Susan E. Stuber, Naomi L.C. Luban, Alan R. Cohen, Sara Pressel, Robert J. Adams - The Lancet 2015 cited by 514

  10. Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

    Authors: Elliott Vichinsky, Lynne Neumayr, Ann N. Earles, Roger Williams, Evelyne T. Lennette, Deborah Dean, Bruce G. Nickerson, Eugene P. Orringer, Virgil McKie, Rita Bellevue, Charles Daeschner, Miguel R. Abboud, Mark D. Moncino, Samir K. Ballas, Russell E. Ware, Elizabeth A. Manci - New England Journal of Medicine 2000 cited by 1,233

  11. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

    Authors: Robert O. Opoka, Christopher M. Ndugwa, Teresa Latham, Adam Lane, Heather Hume, Phillip Kasirye, James S. Hodges, Russell E. Ware, Chandy C. John - Blood 2017 cited by 150

  12. Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination

    Authors: Zhao‐Hua Zhou, Margaret M. Cortese, Jia‐Long Fang, Robert A. Wood, Donna S. Hummell, Kimberly Risma, Allison E. Norton, Mark KuKuruga, Susan Kirshner, Ronald L. Rabin, Cyrus Agarabi, Mary Allen Staat, Natasha Halasa, Russell E. Ware, Anna Ståhl, Maureen McMahon, Peter Browning, Panagiotis Maniatis, Shanna Bolcen, Kathryn M. Edwards, John R. Su, Sai Dharmarajan, Richard A. Forshee, Karen R. Broder, Steven A. Anderson, Steven Kozlowski - Vaccine 2023 cited by 26

  13. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)

    Authors: Russell E. Ware, Ronald W. Helms - Blood 2012 cited by 382

  14. Impact of hydroxyurea on clinical events in the BABY HUG trial

    Authors: Courtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi, Rathi V. Iyer, Phillip Seaman, Jeffrey D. Lebensburger, Ofelia Álvarez, Bruce Thompson, Russell E. Ware, Winfred C. Wang - Blood 2012 cited by 250

  15. How I use hydroxyurea to treat young patients with sickle cell anemia

    Authors: Russell E. Ware - Blood 2010 cited by 390

  16. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology

    Authors: Michelle Tsai, Ashley Kita, Joseph Leach, Ross W.S. Rounsevell, James N. Huang, Joel L. Moake, Russell E. Ware, Daniel A. Fletcher, Wilbur A. Lam - Journal of Clinical Investigation 2011 cited by 296

  17. Management of Sickle Cell Disease Summary of the 2014 Evidence-Based Report by Expert Panel Members

    Authors: Barbara P. Yawn, George R. Buchanan, Araba Afenyi‐Annan, Samir K. Ballas, Kathryn L. Hassell, Allison James, Lanetta Jordan, Sophie Lanzkron, Richard Lottenberg, William Savage, Paula Tanabe, Russell E. Ware, M. Hassan Murad, Jonathan C. Goldsmith, Eduardo Ortíz, Robinson Fulwood, Ann Horton, Joylene John‐Sowah - Survey of Anesthesiology 2015 cited by 270

  18. Empowering newborn screening programs in African countries through establishment of an international collaborative effort

    Authors: Bradford L. Therrell, Michele A. Lloyd-Puryear, Kwaku Ohene‐Frempong, Russell E. Ware, Carmencita D. Padilla, Emmanuela E. Ambrose, Amina Barkat, Hassan Ghazal, Charles Kiyaga, Tisungane Mvalo, Obiageli Nnodu, Karim Ouldim, Mohamed Chérif Rahimy, Brígida Santos, Léon Tshilolo, Careema Yusuf, Guisou Zarbalian, Michael S. Watson - Journal of Community Genetics 2020 cited by 69

  19. Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study

    Authors: Grace Ndeezi, Charles Kiyaga, Arielle G. Hernandez, Deogratias Munube, Thad A. Howard, Isaac Ssewanyana, Jesca Nsungwa, Sarah Kiguli, Christopher M Ndugwa, Russell E. Ware, Jane Ruth Aceng - The Lancet Global Health 2016 cited by 214

  20. Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial

    Authors: Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Makubi, Russell E. Ware, Luke R. Smart - The Lancet Haematology 2023 cited by 33

  21. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

    Authors: Thomas R. Kinney, Ronald W. Helms, Erin E. O’Branski, Kwaku Ohene‐Frempong, Winfred C. Wang, Charles Daeschner, Elliott Vichinsky, Rupa Redding‐Lallinger, Beatrice E. Gee, Orah S. Platt, Russell E. Ware - 1999 cited by 422

  22. Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease

    Authors: Mari Dallas, Brandon M. Triplett, David Shook, Christine Hartford, Ashok Srinivasan, Joseph Laver, Russell E. Ware, Wing Leung - Biology of Blood and Marrow Transplantation 2013 cited by 152

  23. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology

    Authors: Nancy Green, Andrew Zapfel, Obiageli Nnodu, Patience Camille Franklin, Venée N. Tubman, Lulu Chirande, Charles Kiyaga, Catherine Chunda‐Liyoka, Bernard Awuonda, Kwaku Ohene‐Frempong, Baba Inusa, Russell E. Ware, Isaac Odame, Emmanuela E. Ambrose, Livingstone Gayus Dogara, Assaf P. Oron, Chase Willett, Alexis A. Thompson, Nancy Berliner, Thérèsa L. Coetzer, Enrico M. Novelli - Blood Advances 2022 cited by 51

  24. R2* magnetic resonance imaging of the liver in patients with iron overload

    Authors: Jane S. Hankins, M. Beth McCarville, Ralf B. Loeffler, Matthew P. Smeltzer, Mihaela Onciu, Fredric A. Hoffer, Chin-Shang Li, Winfred C. Wang, Russell E. Ware, Claudia M. Hillenbrand - Blood 2009 cited by 371